QS Investors’s Genprex GNPX Stock Holding History

QS Investors’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$125K	–	1144
2021 Q1	$125K	Hold	1	–	–	﹤0.01%	1149
2020 Q4	$120K	Buy	+1	New	+$155K	﹤0.01%	1134

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

QS Investors's GNPX Position: Q2 2021 in Review

QS Investors sold out of Genprex (GNPX) in Q2 2021, closing a stake of 1 share — an estimated $125K sold.

QS Investors first reported a position in GNPX in Q4 2020 and held it in 2 quarters. The position peaked at $125K in Q1 2021. 32 funds tracked by Wall St. Rank hold GNPX as of Q2 2021.

QS Investors reported no remaining Genprex position as of Q2 2021 after selling out during the quarter.
QS Investors sold 1 Genprex share in Q2 2021, an estimated $125K.
QS Investors first reported a position in Genprex in Q4 2020 and held it in 2 quarters.
QS Investors's Genprex position peaked at $125K in Q1 2021.
32 funds tracked by Wall St. Rank held Genprex as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.